45 yr Old female with Major depressive disorder? Diagnosis. She used to have decreased appetite and insomnia so I gave her mirtazapine at night and vit B complex tab with domperidone once daily after breakfast .She is having nausea feeling midway in her lunch and dinners . She is lean thin but fair and in her forties. What blood test and stool tests can be given for which probable gi disorder.
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Searching PubMed
"functional dyspepsia"[MeSH] AND diagnosis
Clinical read of the case
A few things stand out that make this look like more than a simple antidepressant side effect:
- Mirtazapine is actually antiemetic (5-HT3 and H1 antagonism) and typically increases appetite/weight — so new nausea on mirtazapine, despite adding domperidone (a prokinetic/antiemetic), is atypical and worth investigating rather than just increasing psychotropic doses.
- Nausea appearing "midway through lunch and dinner" is a classic postprandial/early-satiety pattern — this localizes the problem to the stomach/proximal gut (delayed gastric emptying, functional dyspepsia, gastritis/PUD) rather than a generalized drug effect.
- Practical point on domperidone dosing: as a prokinetic, domperidone is usually given 3 times daily, 15-30 minutes before meals (half-life ~7-9 hours). A once-daily morning dose after breakfast will have largely worn off by lunch/dinner, so timing alone could explain why nausea is unmasked at those meals. Worth correcting before assuming a new GI disease.
- Lean/thin build, fair skin, 40s female with GI symptoms — this phenotype classically raises suspicion for malabsorption/nutrient-deficiency conditions, of which celiac disease is the textbook example (women affected 2-3x more than men, can present at any age, and "astute clinicians may suspect this disorder when patients present with thin stature, iron deficiency anemia, weight loss, chronic bloating" - Henry's Clinical Diagnosis and Management by Laboratory Methods, p. 294).
Probable GI differentials, ranked
- Functional dyspepsia / gastroparesis (postprandial nausea, early satiety - most consistent with the symptom pattern described)
- H. pylori-related gastritis or peptic ulcer disease
- Celiac disease (given the lean/thin, fair-skinned phenotype)
- Metabolic/endocrine mimics that present with dysmotility-type nausea (hypothyroidism, undiagnosed diabetes causing early gastroparesis)
Blood tests to order
| Test | Purpose |
|---|---|
| CBC with peripheral smear | Screen for iron-deficiency (microcytic) or B12/folate-deficiency (macrocytic) anemia - common in celiac disease and chronic malabsorption |
| Iron studies (ferritin, serum iron, TIBC) | Malabsorption marker, supports celiac work-up |
| Vitamin B12 and folate levels | Malabsorption / nutrient deficiency (also relevant since she's already on B-complex empirically) |
| tTG-IgA + total serum IgA (add tTG-IgG or deamidated gliadin peptide IgG if IgA-deficient) | First-line serologic screen for celiac disease; must confirm with duodenal biopsy if positive (Henry's Clinical Diagnosis and Management by Laboratory Methods, p. 294-300) |
| TSH, free T4 | Thyroid dysfunction can cause dyspepsia-like symptoms and unexplained weight/build changes |
| Fasting glucose / HbA1c | Diabetic gastroparesis is a common organic cause of postprandial nausea |
| Renal function (urea, creatinine, electrolytes) | Uremia is a recognized cause of chronic nausea (Yamada's Textbook of Gastroenterology, Box 32.2) |
| Liver function tests, serum amylase/lipase | Rule out hepatobiliary disease or pancreatitis as a cause of postprandial nausea |
| ESR/CRP | Screen for inflammatory process (e.g., Crohn's disease can present this way) |
| H. pylori serology (IgG) - optional | Less specific than stool antigen; mainly useful if stool testing unavailable |
Stool tests to order
| Test | Purpose |
|---|---|
| H. pylori stool antigen test | First-line, sensitive and specific noninvasive test for active H. pylori infection - FDA-approved for both initial diagnosis and post-treatment monitoring (Harrison's Principles of Internal Medicine, p. 1068; Yamada's Textbook of Gastroenterology). Ideally done off PPIs for 2 weeks and antibiotics/bismuth for 4 weeks to avoid false negatives. |
| Fecal occult blood / fecal immunochemical test (FOBT/FIT) | Screen for occult GI bleeding from gastritis, PUD, or malignancy |
| Stool routine microscopy / ova and parasites (esp. Giardia) | Parasitic infection can cause chronic postprandial nausea and bloating |
| Fecal fat / fecal elastase-1 | If steatorrhea or pancreatic exocrine insufficiency is suspected as part of a malabsorptive picture |
| Fecal calprotectin | If inflammatory bowel disease is on the differential |
Next step if labs are equivocal
If the initial panel is unrevealing but symptoms persist, an upper GI endoscopy (EGD) with duodenal biopsy is the definitive step - it evaluates for gastritis/PUD directly, confirms celiac disease histologically if serology is positive, and can be paired with a gastric emptying scintigraphy study if gastroparesis remains suspected clinically.
A word of caution: this is decision-support information, not a substitute for an in-person GI/internal medicine evaluation - the actual test selection should be tailored after a proper history (duration, associated diarrhea/constipation/weight loss, alarm features like GI bleeding or dysphagia) and physical exam.
This is a shared conversation. Sign in to Orris to start your own chat.